“Very friendly staff, very helpful and very professional. Would highly recommend to family and friends.”
Diabetic Macular Edema: Protecting Your Central Vision
Who Is at Risk
DME can affect anyone with diabetes, but certain factors increase the likelihood of developing the condition. Knowing your personal risk factors helps guide how often you should be screened and how carefully your diabetes needs to be managed.
The longer a person lives with diabetes, the greater the chance of developing DME. This is because blood vessel damage accumulates gradually over years, making long-term monitoring essential for anyone with a diabetes diagnosis regardless of how well-controlled their condition appears to be.
Poor blood sugar control is one of the strongest risk factors for DME. A glycated hemoglobin level, known as HbA1c, above the target range recommended by your doctor is associated with significantly greater risk. High blood pressure and elevated cholesterol also contribute to retinal blood vessel damage and increase the likelihood of fluid leaking into the macula.
Several additional factors can raise the risk of developing DME. Your retina specialist will consider all of these when evaluating your eye health.
- The presence and severity of diabetic retinopathy
- Diabetic kidney disease, which signals widespread blood vessel damage throughout the body
- Pregnancy in women with diabetes, which can temporarily worsen retinopathy and swelling
- Ethnicity, with higher rates observed in certain populations including Hispanic and African American individuals
Signs and Symptoms
DME does not always cause noticeable symptoms at first, which is one of the reasons it can be easy to overlook without regular eye care. Knowing what to watch for can help you seek attention before significant damage occurs.
In its early stages, DME may cause no visible changes in your vision at all. The amount of fluid accumulating in the macula may be too small to affect what you see, even while damage is progressing. This is why routine dilated eye exams are so important for anyone living with diabetes, even when vision feels completely normal.
As DME progresses, it begins to affect the central vision needed for detailed tasks. Changes can be gradual or may appear more quickly depending on the severity of fluid buildup.
- Blurred or distorted central vision
- Difficulty reading or seeing fine print
- Trouble recognizing faces
- Colors that appear washed out or faded
- Dark or empty areas in the center of your visual field
These changes may affect one or both eyes. If left untreated, chronic macular swelling can cause irreversible damage and lasting vision loss. Any new change in vision should prompt a prompt call to a retina specialist.
Some symptoms require immediate attention and should not be waited on. If you notice a sudden increase in floaters, flashes of light, a curtain or shadow falling over your vision, or sudden vision loss in one eye, go to an emergency room or contact a retina specialist right away. These may be signs of a more serious retinal problem that needs prompt treatment to preserve sight.
Diagnosis and Testing
Accurately diagnosing DME requires a combination of clinical examination and advanced imaging. Our team uses several tools to assess the health of your macula, identify the extent of fluid buildup, and guide your treatment plan.
A retina specialist will begin with a dilated eye exam. Special drops are used to widen the pupil, allowing a detailed view of the retina and macula. This exam can reveal signs of fluid accumulation, blood vessel damage, and other changes associated with diabetic retinopathy and DME.
Optical coherence tomography, or OCT, is a noninvasive imaging test that creates detailed cross-section images of the retina. It allows our team to precisely measure the thickness of the macula and detect even small amounts of fluid. OCT is one of the most valuable tools for diagnosing DME and tracking how well treatment is working over time. We perform serial retinal imaging at every visit so that we can compare results side by side and detect any changes in your macula early.
In fluorescein angiography, a dye is injected into a vein in the arm and photographs are taken as the dye travels through the retinal blood vessels. This test reveals exactly where fluid is leaking and helps our team identify damaged vessels and plan the most appropriate treatment approach.
A standard visual acuity test measures how clearly you can see at different distances. While this test alone cannot diagnose DME, it helps our team understand how much your central vision has already been affected and provides a baseline for measuring improvement or decline after treatment begins.
Treatment Options
There are several effective treatments available for DME, and the right approach depends on the severity of your condition and how your eye responds over time. Our team will work with you to develop a personalized treatment plan based on your imaging results, vision, and overall health.
Anti-VEGF therapy is currently the first-line treatment for most patients with DME. These medications are injected directly into the eye, a procedure called an intravitreal injection, to block the VEGF protein that drives fluid leakage. By reducing VEGF activity, these injections help decrease swelling in the macula and can improve or stabilize vision.
Several anti-VEGF medications are used for DME, including Avastin (bevacizumab), Lucentis (ranibizumab), Eylea (aflibercept), and Vabysmo (faricimab). Each has its own dosing schedule, and your retina specialist will recommend the option best suited to your individual situation.
For some patients, inflammation plays a larger role in DME, and corticosteroid therapy may be more effective than anti-VEGF injections alone. Iluvien (fluocinolone acetonide implant) is a long-acting steroid implant that delivers sustained therapy inside the eye for an extended period. A retina specialist may recommend steroid treatment when anti-VEGF therapy has not produced adequate results or when inflammation is a significant part of the condition.
Laser photocoagulation, a thermal laser treatment applied to the retina, was the standard care for DME for many years. A focused beam of light seals leaking blood vessels and helps reduce fluid accumulation. While anti-VEGF injections have largely become the primary treatment approach, laser therapy is still used in certain cases, often in combination with injections, when injections alone are not providing sufficient benefit.
What to Expect During Treatment
Starting treatment for DME can feel like a significant commitment, especially when injections are involved. Understanding what the process looks like can help you feel more prepared and confident in moving forward with care.
Intravitreal injections are performed in our office and typically take only a few minutes. The eye is numbed with anesthetic drops before the procedure, and most patients feel brief pressure or mild discomfort rather than sharp pain. Some temporary redness, mild soreness, or new floaters may occur afterward, but these effects typically resolve within a few days.
DME treatment usually requires a series of injections, particularly during the first year. Most treatment plans begin with monthly injections for the initial loading phase, followed by extended intervals based on how the eye responds. Our team will use OCT imaging and visual acuity measurements at each visit to guide these decisions. Regular follow-up is essential because DME can return if treatment is reduced too quickly or monitoring lapses.
Anti-VEGF treatment can stabilize vision in most patients and improve vision in many. However, results vary depending on how long DME has been present, the severity of swelling, and how well blood sugar is controlled overall. Some patients experience meaningful visual improvement, while others benefit from stabilization that prevents further decline. Complete restoration of vision is not typical, but consistent treatment gives you the best chance of preserving what you have.
Living With Diabetic Macular Edema
Managing DME is an ongoing process that extends beyond your eye care appointments. The choices you make every day can directly affect your retinal health and the long-term success of your treatment.
Keeping your blood sugar within the target range set by your primary care doctor or endocrinologist is one of the most effective ways to slow the progression of DME. Managing blood pressure and cholesterol through medication, diet, and exercise also supports retinal blood vessel health. Eye treatment and diabetes management work together, and improvements in one area can positively influence the other.
If DME has already affected your central vision, practical adjustments can help you maintain daily independence. Large-print materials, magnifying lenses, improved lighting, and high-contrast settings on phones or computers can make reading and other tasks easier. A low vision specialist can provide personalized recommendations tailored to your level of vision loss.
Even when DME appears well controlled, ongoing monitoring is necessary. Fluid can return months or years after successful treatment, and new areas of leakage can develop without warning. All people with diabetes should have a dilated eye exam at least once a year, and more frequent exams are needed if DME or diabetic retinopathy has already been diagnosed. Keeping your scheduled appointments is one of the most important things you can do to protect your remaining vision.
Frequently Asked Questions
Here are answers to some of the questions we hear most often from patients managing diabetic macular edema.
In many cases, treatment significantly reduces the fluid in the macula and improves vision, but DME is managed rather than permanently eliminated. If fluid has been present for a long time, some structural changes in the macula may be difficult to fully reverse. Starting treatment early and attending all follow-up appointments gives you the best opportunity to preserve and potentially improve your sight.
The number of injections varies considerably from person to person. Many plans start with monthly injections for the first several months, then extend to longer intervals depending on how the eye responds. Some patients require ongoing injections for years, while others eventually reach a point where monitoring alone is sufficient. Your retina specialist will adjust your schedule based on OCT findings and visual acuity at each visit, so no two treatment plans look exactly alike.
Yes, very much so. While blood sugar control alone will not eliminate existing macular swelling, keeping your HbA1c within a healthy range reduces ongoing damage to retinal blood vessels and supports the effectiveness of your eye treatment. Patients who maintain stable blood sugar tend to have fewer recurrences of fluid in the macula and better long-term outcomes. Collaborating closely with both your primary care team and your retina specialist is important.
If vision continues to change despite active treatment, it is important to have an honest conversation with your retina specialist rather than waiting to see if it improves on its own. Switching to a different anti-VEGF agent, adding corticosteroid therapy, or combining approaches may produce better results. Declining vision during treatment is a sign that the current plan may need to be adjusted, and your retina specialist can help determine the best next step.
Anti-VEGF injections have been used to treat retinal conditions for many years, and a substantial body of evidence supports their long-term safety. As with any procedure, small risks exist, including a low chance of infection, bleeding, or temporary changes in eye pressure. Serious complications are rare. Our team monitors your eyes closely at every visit and will discuss any concerns about ongoing therapy, helping you weigh the benefits of preserving vision against the risks of continued treatment.
Diabetic retinopathy refers broadly to the damage that diabetes causes to blood vessels throughout the entire retina. DME is a specific complication within that condition, defined by fluid collecting in the macula. You can have diabetic retinopathy without DME, but DME does not occur outside the context of retinopathy. Because the two conditions overlap significantly, both need to be monitored and may require separate but coordinated treatments.
Schedule Your Evaluation at Atlantic Retina Center
If you have diabetes and have not had a dilated eye exam recently, or if you are experiencing any changes in your central vision, we encourage you to reach out to our team. Atlantic Retina Center serves patients across the Eastern Shore of Maryland and central and southern Delaware with specialized, single-specialty retinal care focused entirely on the retina, vitreous, and macula. Our retina specialists are experienced in managing all stages of diabetic macular edema and are committed to helping you protect your vision for the long term.